(Q37300066)

19 August 2017

Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use. (English)

1 reference

19 August 2017

1 reference

11

Ludwig Kappos

1 reference

19 August 2017

5

Giancarlo Comi

1 reference

19 August 2017

Paul W O'Connor

1

1 reference

19 August 2017

Fred D Lublin

2

1 reference

19 August 2017

Jerry S Wolinsky

3

1 reference

19 August 2017

Christian Confavreux

4

1 reference

19 August 2017

Mark S Freedman

6

1 reference

19 August 2017

Tomas P Olsson

7

1 reference

19 August 2017

Aaron E Miller

8

1 reference

19 August 2017

Catherine Dive-Pouletty

9

1 reference

19 August 2017

Gaëlle Bégo-Le-Bagousse

10

1 reference

19 August 2017

14 July 2013

1 reference

19 August 2017

1 reference

19 August 2017

260

1 reference

19 August 2017

10

1 reference

19 August 2017

2472-2480

1 reference

Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Improving quality of life in multiple sclerosis: an unmet need.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Economic burden of multiple sclerosis: a systematic review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

The costs and consequences of multiple sclerosis relapses: a managed care perspective

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

The emotional and psychological impact of multiple sclerosis relapses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

The natural history of relapses in multiple sclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Effect of relapses on development of residual deficit in multiple sclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824843

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

2 September 2018

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study

1 reference

12 December 2020

Multiple sclerosis relapses: a multivariable analysis of residual disability determinants

1 reference

12 December 2020

10.1007/S00415-013-6979-Y

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23852658

1 reference